Patents by Inventor Sun Ho

Sun Ho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation
    Publication number: 20100291111
    Abstract: The present invention provides methods for direct killing of cancer cells using anti-?5?1 antibodies. Generally, the method comprises contacting a cancer cell that expresses ?5?1 on its surface with an anti-?5?1 antibody, and thereby inducing the death of the cancer cell. The methods of the invention may be employed at an early stage of cancer development in a patient to prevent tumor establishment. In addition, the methods may be used to treat previously formed tumors especially in cancer that have not proven susceptible to anti-angiogenesis therapy. The methods may be employed as a combination therapy of anti-?5?1 antibodies together with cancer chemotherapeutic agents or other molecular-based cancer therapeutic agents.
    Type: Application
    Filed: December 18, 2009
    Publication date: November 18, 2010
    Applicant: FACET BIOTECH
    Inventors: VANITHA RAMAKRISHNAN, VINAY BHASKAR, SUN HO, RICHARD MURRAY, DEBBIE LAW
  • Use of anti-?5?1 antibodies to inhibit cancer cell proliferation
    Patent number: 7662384
    Abstract: The present invention provides methods for direct killing of cancer cells using anti-?5?1 antibodies. Generally, the method comprises contacting a cancer cell that expresses ?5?1 on its surface with an anti-?5?1 antibody, and thereby inducing the death of the cancer cell. The methods of the invention may be employed at an early stage of cancer development in a patient to prevent tumor establishment. In addition, the methods may be used to treat previously formed tumors especially in cancer that have not proven susceptible to anti-angiogenesis therapy. The methods may be employed as a combination therapy of anti-?5?1 antibodies together with cancer chemotherapeutic agents or other molecular-based cancer therapeutic agents.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: February 16, 2010
    Assignee: Facet Biotech Corporation
    Inventors: Vanitha Ramakrishnan, Vinay Bhaskar, Sun Ho, Richard Murray, Debbie Law
  • Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
    Publication number: 20050260210
    Abstract: The present invention provides methods for direct killing of cancer cells using anti-?5?1 antibodies. Generally, the method comprises contacting a cancer cell that expresses ?5?1 on its surface with an anti-?5?1 antibody, and thereby inducing the death of the cancer cell. The methods of the invention may be employed at an early stage of cancer development in a patient to prevent tumor establishment. In addition, the methods may be used to treat previously formed tumors especially in cancer that have not proven susceptible to anti-angiogenesis therapy. The methods may be employed as a combination therapy of anti-?5?1 antibodies together with cancer chemotherapeutic agents or other molecular-based cancer therapeutic agents.
    Type: Application
    Filed: March 24, 2005
    Publication date: November 24, 2005
    Inventors: Vanitha Ramakrishnan, Vinay Bhaskar, Sun Ho, Richard Murray, Debbie Law